Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 26;18(6):e0275560.
doi: 10.1371/journal.pone.0275560. eCollection 2023.

The epidemiology of HIV population viral load in twelve sub-Saharan African countries

Affiliations

The epidemiology of HIV population viral load in twelve sub-Saharan African countries

Wolfgang Hladik et al. PLoS One. .

Abstract

Background: We examined the epidemiology and transmission potential of HIV population viral load (VL) in 12 sub-Saharan African countries.

Methods: We analyzed data from Population-based HIV Impact Assessments (PHIAs), large national household-based surveys conducted between 2015 and 2019 in Cameroon, Cote d'Ivoire, Eswatini, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe. Blood-based biomarkers included HIV serology, recency of HIV infection, and VL. We estimated the number of people living with HIV (PLHIV) with suppressed viral load (<1,000 HIV-1 RNA copies/mL) and with unsuppressed viral load (viremic), the prevalence of unsuppressed HIV (population viremia), sex-specific HIV transmission ratios (number female incident HIV-1 infections/number unsuppressed male PLHIV per 100 persons-years [PY] and vice versa) and examined correlations between a variety of VL metrics and incident HIV. Country sample sizes ranged from 10,016 (Eswatini) to 30,637 (Rwanda); estimates were weighted and restricted to participants 15 years and older.

Results: The proportion of female PLHIV with viral suppression was higher than that among males in all countries, however, the number of unsuppressed females outnumbered that of unsuppressed males in all countries due to higher overall female HIV prevalence, with ratios ranging from 1.08 to 2.10 (median: 1.43). The spatial distribution of HIV seroprevalence, viremia prevalence, and number of unsuppressed adults often differed substantially within the same countries. The 1% and 5% of PLHIV with the highest VL on average accounted for 34% and 66%, respectively, of countries' total VL. HIV transmission ratios varied widely across countries and were higher for male-to-female (range: 2.3-28.3/100 PY) than for female-to-male transmission (range: 1.5-10.6/100 PY). In all countries mean log10 VL among unsuppressed males was higher than that among females. Correlations between VL measures and incident HIV varied, were weaker for VL metrics among females compared to males and were strongest for the number of unsuppressed PLHIV per 100 HIV-negative adults (R2 = 0.92).

Conclusions: Despite higher proportions of viral suppression, female unsuppressed PLHIV outnumbered males in all countries examined. Unsuppressed male PLHIV have consistently higher VL and a higher risk of transmitting HIV than females. Just 5% of PLHIV account for almost two-thirds of countries' total VL. Population-level VL metrics help monitor the epidemic and highlight key programmatic gaps in these African countries.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Distribution of ARV-negative PLHIV by viral load category and by sex.
12 Population-based HIV Impact Assessments, 2015–19. ARV: antiretroviral; PLHIV: people living with HIV; ND: Not detectable; K denotes values in thousands, M in millions.
Fig 2
Fig 2. Median log10 viral load among ARV-negative PLHIV by CD4+ T cell count category and sex.
10 Population-based HIV Impact Assessments, 2015–19. Bars represent the 25th and 75th percentiles. ARV: antiretroviral; PLHIV: people living with HIV. Across all CD4 strata, the median viral load among males was 4.766; among females, 4.481.
Fig 3
Fig 3. Estimated number of suppressed and unsuppressed PLHIV by sex and age group.
Population-based HIV Impact Assessments, 2015–2019. PLHIV: (adult) people living with HIV. Dark blue color: Males unsuppressed, Light blue color: males suppressed, Dark orange color: females unsuppressed, Light orange color: females suppressed.
Fig 4
Fig 4. Subnational HIV seroprevalence, viremia prevalence, and number unsuppressed PLHIV, 12 Population-based HIV Impact Assessments, 2015–19.
Viremia prevalence indicates the estimated percentage of the adult population (HIV-infected and uninfected) with unsuppressed viral load. No. unsuppressed PLHIV indicates the estimated number of adult unsuppressed PLHIV per pixel (100m by 100m square). Note: The coloring ramp may not correlate in linear fashion with the count values of unsuppressed PLHIV, and maps should be compared within, rather than across, countries.
Fig 5
Fig 5. Lorenz curves for the distribution of viral load.
12 Population-based HIV Impact Assessments, 2015–2019. The x-axis displays the cumulative percent of all adult PLHIV ranked by viral load. The y-axis displays the cumulative percent of total VL. PLHIV: people living with HIV.

References

    1. UNAIDS Fact Sheet 2022. Joint United Nations Programme on AIDS, Geneva, 2022. Accessed at https://www.unaids.org/en/resources/fact-sheet.
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al.. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9. Epub 2016/07/19. doi: 10.1056/NEJMoa1600693 ; PubMed Central PMCID: PMC5049503. - DOI - PMC - PubMed
    1. Prevailing Against Pandemics. WAD Report 2020. Joint United Nations Programme on HIV/AIDS. Geneva. 2020. Accessed 2-Jan-2023 at https://aidstargets2025.unaids.org/assets/images/prevailing-against-pand....
    1. Tanser F, Vandormael A, Cuadros D, Phillips AN, de Oliveira T, Tomita A, et al.. Effect of population viral load on prospective HIV incidence in a hyperendemic rural African community. Sci Transl Med. 2017;9(420). Epub 2017/12/15. doi: 10.1126/scitranslmed.aam8012 ; PubMed Central PMCID: PMC6435884. - DOI - PMC - PubMed
    1. Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T, et al.. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? Journal of the International AIDS Society. 2020;23(2):e25455. doi: 10.1002/jia2.25455 - DOI - PMC - PubMed

Publication types

Substances